Michelle Hsiang

Mentoring in Clinical Trials and Patient-Oriented Research in Infectious Diseases and Global Health

National Institute of Allergy and Infectious Diseases · K24

Contact PI · $207.7K · University of California, San Francisco

Focal Mass Drug Administration (fMDA) to Reduce Plasmodium Vivax Transmission, a Pragmatic Cluster Randomized Controlled Trial in Peru

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $6.3M · University of California, San Francisco

Long-Term Health and Socioeconomic Impact of Interventions Targeting Low-Density Malaria Infection (LMI) Among Children in Tanzaniav

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $5.4M · University of California, San Francisco

Evaluating Re-Active Surveillance Strategies for Malaria Elimination in Swaziland

National Institute of Allergy and Infectious Diseases · K23

Contact PI · $657.5K · Ut Southwestern Medical Center

FocaL Mass Drug Administration for Vivax Malaria Elimination

Principal investigator · Recruiting · Phase 3

University of California, San Francisco

CHILD (Child Health and Infection With Low Density) Malaria

Principal investigator · Completed

University of California, San Francisco

Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Principal investigator · Completed

University of California, San Francisco

Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia

Principal investigator · Completed · Phase 3

University of California, San Francisco